WE MOVE - Wilson Disease - Treatment
The goal of drug therapy in individuals with Wilson disease is to remove excess copper from the body and prevent ongoing copper accumulation and deposition. Therefore, drug therapy must be continued throughout life. Inadequate treatment or ... [... more]
We Move |
Tics (Pediatric) Overview
In this section, several complex motor phenomena are defined, including tics, compulsions, stereotypies, mannerisms, and habits. Syndromes that have a sense of motor restlessness, including akathisia and restless legs syndrome, are also ... [... more]
We Move |
Symptoms, Findings, and Clinical Course of Huntington's ...
The symptoms of HD may vary in range and severity, age at onset, and rate of clinical progression from patient to patient–including among members of the same family (kindred). The peak age of adult-onset HD is between 35 to 50 years. A small ... [... more]
We Move |
Bradykinesia
Bradykinesia means slow movement. In the context of childhood movement disorders, bradykinesia essentially refers to a component of parkinsonism. The full spectrum of parkinsonism is derived from the features of Parkinson's disease, which include ... [... more]
We Move |
Overview of Sydenham's Chorea
Sydenham's chorea is a neurologic movement disorder characterized by irregular, abrupt, relatively rapid involuntary movements (i.e., chorea) of muscles of the face, neck, trunk, and arms and legs (limbs). Sydenham's chorea is a neurologic ... [... more]
We Move |
WE MOVE - Ataxia
Ataxia describes a lack of coordination while performing voluntary movements. It may appear as clumsiness, inaccuracy, or instability. Movements are not smooth and may appear disjointed or jerky. » Adult Ataxia Information for Patients and ... [... more]
We Move |
WE MOVE - Tourette's Syndrome - Treatment
The goal of therapy in patients with TS is to reduce motor and vocal tics and alleviate associated behavioral problems, such as obsessive-compulsive behaviors, ADHD, and impulsivity. The goal of therapy in patients with TS is to reduce motor and ... [... more]
We Move |
Progressive Supranuclear Palsy
Progressive Supranuclear Palsy Information for Patients and Caregivers Progressive supranuclear palsy (PSP) is a rapidly progressing degenerative disease whose cause is unknown. Degeneration of cells in several brain areas causes a variety of ... [... more]
We Move |
Essential Tremor
If you, a member of your family, or someone you care about is affected by essential tremor (ET), please read this section. You will find information about the primary features of ET, its potential causes, and effective treatment options. Medical ... [... more]
We Move |
Spasticity Treatment
In some patients with mild spasticity, the best treatment may be no treatment, with a watch-and-wait strategy. Typically, treatment is reserved for spasticity that causes pain, interferes with activities of daily living or sleep, or leads to ... [... more]
We Move |
Corticobasal Degeneration
Corticobasal Degeneration Information for Patients and Caregivers WE MOVE - Corticobasal Degeneration » Corticobasal Degeneration Information for Patients and Caregivers (see table of contents below) » Corticobasal Degeneration Information [... more]
We Move |
WE MOVE - Treatment of Pediatric Movement Disorders
Treatment of Pediatric Movement Disorders - Table of Contents Treatment of Pediatric Movement Disorders - Information for Parents and Caregivers Scientific Reviewers: Leon Dure, MD, Associate Professor of Pediatrics and Neurology, The University ... [... more]
We Move |
